Reuters logo
BRIEF-Sanofi Ends Development Of Clostridium Difficile Vaccine
December 1, 2017 / 9:10 PM / 12 days ago

BRIEF-Sanofi Ends Development Of Clostridium Difficile Vaccine

Dec 1 (Reuters) - SANOFI:

* REG-SANOFI ENDS DEVELOPMENT OF CLOSTRIDIUM DIFFICILE VACCINE

* ‍INDEPENDENT DATA MONITORING COMMITTEE (IDMC) FOR PHASE III CDIFFENSE CLINICAL TRIAL PROGRAM CONCLUDED THAT PROBABILITY THAT STUDY WILL MEET ITS PRIMARY OBJECTIVE IS LOW​

* ‍DECIDED TO DISCONTINUE CLINICAL DEVELOPMENT OF ITS EXPERIMENTAL CLOSTRIDIUM DIFFICILE VACCINE​ Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below